Antitrust Featured Generic Drugs Greg Curfman Health Law Policy Intellectual Property Pharmaceuticals Public Health
FTC v. Actavis
-
-
When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims
Read more: When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims -
Supreme Court Decision on FTC v. Actavis paves the way for development of cheaper drugs
Read more: Supreme Court Decision on FTC v. Actavis paves the way for development of cheaper drugs